“ Alzheimer’s is a devastating disease, not just for those with Alzheimer’s, but for their families as well. It robs people of their memories and their ability to function independently. But with research, we can find a way to slow or stop the progression of this disease.” – Shelley Moore Capito
Venue: UTAS Muscat Auditorium
College of Computing and Information Sciences,
University of Technology and Applied Sciences, Muscat
in collaboration with Oman Alzheimer’s Society
The aim of the research colloquium on Alzheimer’s disease is to bring together doctors, technologists, and researchers in one platform to discuss and share the latest advances and cutting-edge approaches to Alzheimer’s disease diagnosis and treatment. By fostering collaboration and innovation, the colloquium aims to improve our understanding of Alzheimer’s disease mechanisms, risk factors, and potential interventions. It also provides a platform for researchers, particularly those from Oman, to showcase their work and engage in meaningful discussions with their peers and moderators. Overall, the goal of the colloquium is to contribute to the global effort to fight Alzheimer’s disease and to make progress towards effective treatments and ultimately a cure.
To provide a forum for doctors, technologists, and researchers to share the latest advances and cutting-edge approaches to Alzheimer’s disease diagnosis and treatment.
To facilitate collaboration between participants from diverse backgrounds and disciplines, with the aim of fostering new ideas and approaches for improving our understanding of Alzheimer’s disease mechanisms, risk factors, and potential interventions.
To showcase the work of researchers, particularly those from Oman, and provide an opportunity for them to receive feedback and engage in meaningful discussions with their peers and moderators.
To raise awareness about Alzheimer’s disease and the importance of ongoing research to improve diagnosis, treatment, and ultimately find a cure.
To identify potential areas of future research and collaboration, with the aim of advancing our understanding of Alzheimer’s disease and developing more effective interventions to treat and prevent the disease.
To apply for an international funding after making a research protocol for the disease